
Low-Dose Aspirin May Increase Anaemia Risk in Healthy Seniors
ASPREE trial — ASPirin in Reducing Events in the Elderly A recent study using data from the significant ASPREE trial has revealed a 20% heightened likelihood of anaemia in certain older adults, primarily those aged 70 years or above, due to prolonged daily aspirin usage. The ASPREE-Anaemia sub-study, a part of the larger ASPREE trial, … Continued
Read more